- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01600404
Effects of Antimuscarinics on Cognition in Spinal Cord Injury
Effects of Antimuscarinic Drugs on the Cognition of Patients With Acute Spinal Cord Injury
Prospective evaluation of the cognitive function of in-house patients suffering from an acute traumatic spinal cord injury before and three months after the initiation of antimuscarinic treatment.
The following hypothesis will be tested: Antimuscarinic treatment results in significantly worse cognitive test results three months after traumatic spinal cord injury compared to the pre-treatment results and the results of the control group.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
There will be two groups: 1) patients receiving antimuscarinic treatment 2) patients without antimuscarinic treatment (control).
The control group will be investigated in order to determine the effects of traumatic spinal cord injury on cognition and the natural history of potential cognitive impairment within the first three months after spinal cord injury.
Six to eight weeks after traumatic spinal cord injury, patients are examined in order to determine the type of neurogenic bladder dysfunction they are suffering from. Patients suffering from an overactive bladder will receive antimuscarinic treatment in order to prevent high urine storage and voiding pressures, that put the kidneys at risk.
Prior to the urologic examination, patients fulfilling inclusion criteria will be contacted. If informed consent is given, cognitive function will be evaluated in both patient groups using different standard neuropsychologic tests. The same neuropsychologic tests will be repeated three months later. Evaluation will take place under standardized conditions (e.g. time of day).
Furthermore,different factors influencing cognition, e.g. depression, pain, medication, will be assessed at the beginning and end of the study.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
LU
-
Nottwil, LU, Schweiz, 6207
- Swiss Paraplegic Centre
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- acute traumatic spinal cord injury
- primary rehabilitation / in-house patient
- 18-65 years of age
- treatment group: indication for antimuscarinic treatment (oxybutynin, tolterodine
- willingness and motivation to participate in study
Exclusion Criteria:
- lesion level above C4
- traumatic brain injury (initial Glasgow Coma Score < 13)
- pre-existing dementia
- pre-existing impaired cognitive function
- previous antimuscarinic treatment
- treatment group: antimuscarinic treatment other than oxybutynin, tolterodine
- acute psychologic disorders, diseases, schizophrenia
- alcohol abuse, consumption of illegal drugs (incl. marijuana)
- moderate to severe depression (Beck Depression Inventory Score > 18)
- moderate to severe pain (International Spinal Cord Injury Pain Basic Data Set)
- progressive disease
- tricyclic antidepressant
- color blindness, impaired sight, blindness
- insufficient German language skills
- no informed consent
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Kohorte
- Tidsperspektiver: Fremadrettet
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
---|---|
antimuscarinic treatment
|
|
no antimuscarinic treatment (control)
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
d2 Test
Tidsramme: change from enrollement to 3 months
|
change from enrollement to 3 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
International Spinal Cord Injury Pain Basic Data Set
Tidsramme: day 0 and at 3 months
|
day 0 and at 3 months
|
|
Beck Depression Inventory Score
Tidsramme: day 0 and at 3 months
|
day 0 and at 3 months
|
|
patientegenskaber
Tidsramme: dag 0
|
alder
|
dag 0
|
type of neurologic lower urinary tract dysfunction
Tidsramme: day 0
|
day 0
|
|
Stroop Test
Tidsramme: day 0 and at 3 months
|
day 0 and at 3 months
|
|
California Verbal Learning Test
Tidsramme: day 0 and at 3 months
|
day 0 and at 3 months
|
|
Verbal Fluency Test according to Thurstone
Tidsramme: day 0 and at 3 months
|
day 0 and at 3 months
|
|
visuospatial performance
Tidsramme: day 0 and at 3 months
|
subtests from Wechsler Adult Intelligence Scale
|
day 0 and at 3 months
|
divided attention
Tidsramme: day 0 and at 3 months
|
subtests from test battery according to Zimmermann and Fimm
|
day 0 and at 3 months
|
patientegenskaber
Tidsramme: dag 0
|
køn
|
dag 0
|
patient characteristics
Tidsramme: day 0
|
date of injury
|
day 0
|
patient characteristics
Tidsramme: day 0
|
tpe of accident
|
day 0
|
patient characteristics
Tidsramme: day 0
|
Glasgow Coma Scale
|
day 0
|
patient characteristics
Tidsramme: day 0
|
lesion level
|
day 0
|
patient characteristics
Tidsramme: day 0
|
completeness of injury
|
day 0
|
patient characteristics
Tidsramme: day 0
|
ASIA impairment score
|
day 0
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Jürgen Pannek, Prof, Swiss Paraplegic Centre
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
- Psykiske lidelser
- Sygdomme i centralnervesystemet
- Sygdomme i nervesystemet
- Neurokognitive lidelser
- Traumer, nervesystemet
- Rygmarvssygdomme
- Kognitionsforstyrrelser
- Sår og skader
- Kognitiv dysfunktion
- Rygmarvsskader
- Lægemidlers fysiologiske virkninger
- Neurotransmittermidler
- Molekylære mekanismer for farmakologisk virkning
- Kolinerge antagonister
- Kolinerge midler
- Muskarine antagonister
Andre undersøgelses-id-numre
- 2011-25 (Anden identifikator: AP HM)
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Mild kognitiv svækkelse
-
Johns Hopkins UniversityNational Institute on Aging (NIA)RekrutteringSøvnforstyrrelser | AMCI - Amnestic Mild Cognitive ImpairmentForenede Stater
-
Dart NeuroScience, LLCAfsluttetAge-Associated Memory Impairment (AAMI)Forenede Stater
-
Charité Neurocure AG FlöelUkendtAfasi | Anomi (ord-finding impairment)Tyskland
-
St. Boniface HospitalPizzey Ingredients; Canadian Agricultural PartnershipAktiv, ikke rekrutterendeHukommelse; Forstyrrelse, MildCanada
-
XtremeVRI AGAristotle University Of Thessaloniki; Klinik Hirslanden, Zurich; Greek Alzheimer...AfsluttetSund og rask | Mild kognitiv svækkelse, så angivet | Mild demens
-
Aristotle University Of ThessalonikiGreek Alzheimer's Association and Related DisordersAfsluttetSund og rask | Mild kognitiv svækkelse, så angivet | Mild demens
-
Mitsubishi Tanabe Pharma America Inc.AfsluttetMild og moderat nedsat leverfunktionForenede Stater
-
Maastricht University Medical CenterRekrutteringMild kognitiv svækkelse | Mild demens | Amnestisk mild kognitiv lidelseHolland
-
Mackay Memorial HospitalBened Biomedical Co., Ltd.RekrutteringMild kognitiv svækkelse (MCI)Taiwan
-
Thomas Jefferson UniversityJohns Hopkins University; University of Pennsylvania; National Institute... og andre samarbejdspartnereAfsluttetMild kognitiv svækkelse (MCI)Forenede Stater
Kliniske forsøg med antimuscarinic treatment
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)RekrutteringAutismespektrumforstyrrelse | AutismeForenede Stater
-
University of California, San DiegoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) og andre samarbejdspartnereAfsluttet
-
Stanford UniversityRekrutteringAutismespektrumforstyrrelseForenede Stater
-
Virginia Polytechnic Institute and State UniversityAfsluttetAutismespektrumforstyrrelseForenede Stater
-
Universidad Católica San Antonio de MurciaAfsluttetRygsmerte | Atletiske skader | Rygspænding Nedre rygSpanien
-
Uşak UniversityAfsluttetLivskvalitet | Overholdelse af behandlingKalkun
-
The Cleveland ClinicTwin HealthAktiv, ikke rekrutterende
-
RANDUniversity of California, Los Angeles; Bill and Melinda Gates Foundation; Pathfinder InternationalAfsluttetFamilieplanlægningstjenesterForenede Stater
-
Stanford UniversityAfsluttetSocial Motivation Intervention for Children With Autism Spectrum Disorder: Improving Peer InitiationAutismespektrumforstyrrelseForenede Stater
-
Yale UniversitySimons FoundationAfsluttet